SCHEMBL21030692

SCHEMBL21030692

c1ccc(-c2ccc3ccc4ccc(-c5ccc(-c6c7ccccc7nc7c6sc6ccccc67)cc5)nc4c3n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
KRAS P01116 1/20 0.35
PARP1 P09874 1/20 0.35
LIMK1 P53667 2/20 0.34
SCD O00767 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
ACHE P22303 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
AR P10275 1/20 0.33
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25847632 0.94 TNKS (0.36) TNKSTNKS2ESR1ESR2KRAS
SCHEMBL25847630 0.91 PARP1 (0.35) TNKSTNKS2ESR1ESR2KRAS
SCHEMBL21032091 0.91 KRAS (0.38) TNKSTNKS2ESR1ESR2KRAS
SCHEMBL25847586 0.86 ESR1 (0.44) TNKSTNKS2ESR1ESR2KRAS
SCHEMBL21030572 0.85 ESR1 (0.43) TNKSTNKS2ESR1ESR2KRAS
SCHEMBL21031192 0.85 MEN1 (0.43) TNKSTNKS2ESR1ESR2SCD
SCHEMBL21032090 0.85 MEN1 (0.43) TNKSTNKS2ESR1ESR2SCD
SCHEMBL21030698 0.84 MEN1 (0.42) TNKSTNKS2ESR1ESR2LIMK1
SCHEMBL22763764 0.84 MEN1 (0.42) TNKSTNKS2ESR1ESR2LIMK1
SCHEMBL22763760 0.84 MEN1 (0.42) TNKSTNKS2ESR1ESR2LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 TNKS 3585/4885TNKS2 3491/4885ESR1 448/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 TNKS 3585/4885TNKS2 3491/4885ESR1 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.